https://orcid.org/0000-0002-3416-2900
Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Giulia Liparoti, Beatrice Burchiani, Elisabetta Mencaroni, Domenico Tripodi, Giuseppe Di Cara & Alberto Verrotti. (2022) Individualizing doses of antiepileptic drugs. Expert Opinion on Drug Metabolism & Toxicology 18:3, pages 219-233.
Read now
Read now
Deborah Guery & Sylvain Rheims. (2021) Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies. Neuropsychiatric Disease and Treatment 17, pages 2229-2242.
Read now
Read now
Eleonora Tulli, Giuseppe Di Cara, Giulia Iapadre, Pasquale Striano & Alberto Verrotti. (2021) An update on brivaracetam for the treatment of pediatric partial epilepsy. Expert Opinion on Pharmacotherapy 22:11, pages 1387-1395.
Read now
Read now
Sara Matricardi, Francesca Felicia Operto, Giovanni Farello, Giangennaro Coppola & Alberto Verrotti. (2020) Withdrawal seizures: possible risk factors. Expert Review of Neurotherapeutics 20:7, pages 667-672.
Read now
Read now
Articles from other publishers (29)
D. Mammadova, J. Vecko, M. Hofmann, S. C. Schüssler, L. Deiters, A. Canda, A. K. Wieland, S. Gollwitzer, H. Hamer & Regina Trollmann. (2023) A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Jon Davis Perkins, Mohamed S. Abdelmoneim, Stacy Schantz Wilkins, Saadat Kamran, Boulenouar Mesraoua, Gayane Melikyan, Abdulraheem Alrabi, Ahmed El-Bardissy, Osama Elalamy & Hassan Jassim Al Hail. (2023) Dosage, time, and polytherapy dependent effects of different levetiracetam regimens on cognitive function. Epilepsy & Behavior 148, pages 109453.
Crossref
Crossref
Yaroslav Winter, Katharina Sandner, Martin Glaser, Dumitru Ciolac, Viktoria Sauer, Andreas Ziebart, Ali Karakoyun, Vitalie Chiosa, Assel Saryyeva, Joachim Krauss, Florian Ringel & Sergiu Groppa. (2023) Synergistic effects of vagus nerve stimulation and antiseizure medication. Journal of Neurology 270:10, pages 4978-4984.
Crossref
Crossref
Naciye Çilem Çarkı Bal, Ebru Apaydın Doğan & Yeşim Şenol. (2023) Risk Factors for Clinically Overt Hypothyroidism in Unselected Population of Adult Epilepsy Patients. Archives Of Epilepsy 29:2, pages 46-49.
Crossref
Crossref
Tristan Manfred Stöber, Danylo Batulin, Jochen Triesch, Rishikesh Narayanan & Peter Jedlicka. (2023) Degeneracy in epilepsy: multiple routes to hyperexcitable brain circuits and their repair. Communications Biology 6:1.
Crossref
Crossref
Ivana Damnjanović, Nastia Tsyplakova, Nikola Stefanović, Tatjana Tošić, Aleksandra Catić-Đorđević & Vangelis Karalis. (2023) Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population. Therapeutic Advances in Drug Safety 14.
Crossref
Crossref
Cameron S. Metcalf, Saurabh Gagangras, Grzegorz Bulaj & H. Steve White. (2022) Synergistic effects of the galanin analog 810–2 with the antiseizure medication levetiracetam in rodent seizure models. Epilepsia 63:12, pages 3090-3099.
Crossref
Crossref
Louisa G. Gordon, Thomas M. Elliott, Carmen Bennett, Georgina Hollway, Nicola Waddell & Lata Vadlamudi. (2022) Early cost–utility analysis of genetically guided therapy for patients with drug‐resistant epilepsy. Epilepsia 63:12, pages 3111-3121.
Crossref
Crossref
Tommy Stödberg, Torbjörn Tomson, Britt‐Marie Anderlid, Tomas Andersson, Olivia Henry, Per Åmark & Anna Wedell. (2022) Outcome at age 7 of epilepsy presenting in the first 2 years of life. A population‐based study. Epilepsia 63:8, pages 2096-2107.
Crossref
Crossref
Gianluca Dini, Eleonora Tulli, Giovanni Battista Dell’Isola, Elisabetta Mencaroni, Giuseppe Di Cara, Pasquale Striano & Alberto Verrotti. (2022) Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine. Frontiers in Pharmacology 13.
Crossref
Crossref
Raziyeh Masumshah, Rosa Aghdam & Changiz Eslahchi. (2021) A neural network-based method for polypharmacy side effects prediction. BMC Bioinformatics 22:1.
Crossref
Crossref
Faheem Hyder Pottoo, Mohammed Salahuddin, Firdos Alam Khan, Marwa Abdullah AL Dhamen, Walaa Jafar Alsaeed, Mohamed S. Gomaa, Chittibabu Vatte & Mohammad N. Alomary. (2021) Combinatorial Regimen of Carbamazepine and Imipramine Exhibits Synergism against Grandmal Epilepsy in Rats: Inhibition of Pro-Inflammatory Cytokines and PI3K/Akt/mTOR Signaling Pathway. Pharmaceuticals 14:11, pages 1204.
Crossref
Crossref
Hammad Ahmed, Mahtab Ahmad Khan, Syed Awais Ali Zaidi & Sajjad Muhammad. (2021) In Silico and In Vivo: Evaluating the Therapeutic Potential of Kaempferol, Quercetin, and Catechin to Treat Chronic Epilepsy in a Rat Model. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Wolfgang Löscher. (2021) Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy. Frontiers in Pharmacology 12.
Crossref
Crossref
Opeyemi Samson Osuntokun, Busayo Grace Akingboye, Gbola Olayiwola, Taiwo Adekemi Abayomi & Abiodun Oladele Ayoka. (2021) The impairment of motor coordination following chronic carbamazepine-levetiracetam combination treatment with evidence of corticocerebellar toxicity in male Wistar rats. Brain Research 1767, pages 147565.
Crossref
Crossref
Valeria Venti, Maria Chiara Consentino, Pierluigi Smilari, Filippo Greco, Claudia Francesca Oliva, Agata Fiumara, Raffaele Falsaperla, Martino Ruggieri & Piero Pavone. (2021) Malformations of Cortical Development, Cognitive Involvementand Epilepsy: A Single Institution Experience in 19 Young Patients. Children 8:8, pages 637.
Crossref
Crossref
K. Yu. Mukhin, E. D. Belousova, S. G. Burd, M. V. Barkhatov, N. A. Ermolenko, S. K. Zyryanov, E. I. Karpovich, E. A. Morozova & G. V. Odintsova. (2021) Perampanel in the additional therapy of focal and primary generalized tonic-clonic seizures in children 4–12 years old: clinical data, experience of use and practical recommendations. Epilepsy and paroxysmal conditions 13:2, pages 180-187.
Crossref
Crossref
Jun-Sang Sunwoo, Hyunjin Jo, Kyung Wook Kang, Keun Tae Kim, Daeyoung Kim, Dong Wook Kim, Min-Jee Kim, Saeyoon Kim, Woojun Kim, Hye-Jin Moon, Ha Ree Park, Jung-Ick Byun, Jong-Geun Seo, Sung Chul Lim, Min Kyung Chu, Su-Hyun Han, Kyoung Jin Hwang & Dae-Won Seo. (2021) Survey on Antiepileptic Drug Therapy in Patients with Drug Resistant Epilepsy. Journal of Epilepsy Research 11:1, pages 72-82.
Crossref
Crossref
Antonella Fattorusso, Sara Matricardi, Elisabetta Mencaroni, Giovanni Battista Dell'Isola, Giuseppe Di Cara, Pasquale Striano & Alberto Verrotti. (2021) The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies. Frontiers in Neurology 12.
Crossref
Crossref
Deborah Guery & Sylvain Rheims. (2020) Is the mechanism of action of antiseizure drugs a key element in the choice of treatment?. Fundamental & Clinical Pharmacology 35:3, pages 552-563.
Crossref
Crossref
William E Rosenfeld, Arkady Nisman & Louis Ferrari. (2021) Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study. Epilepsy Research 172, pages 106592.
Crossref
Crossref
Christian Brandt, Lynanne McGuire & Jack Uetrecht. (2021) Severe cutaneous adverse reaction associated with antiseizure medications: Diagnosis, management, and prevention. Epilepsy & Behavior 117, pages 107844.
Crossref
Crossref
Jarogniew J. Łuszczki, Dominika Podgórska, Justyna Kozińska, Marek Jankiewicz, Zbigniew Plewa, Mateusz Kominek, Dorota Żółkowska & Magdalena Florek-Łuszczki. (2020) Polygonogram with isobolographic synergy for three-drug combinations of phenobarbital with second-generation antiepileptic drugs in the tonic–clonic seizure model in mice. Pharmacological Reports 73:1, pages 111-121.
Crossref
Crossref
Claudia Francesca Oliva, Gloria Gangi, Silvia Marino, Lidia Marino, Giulia Messina, Sarah Sciuto, Giovanni Cacciaguerra, Mattia Comella, Raffaele Falsaperla & Piero Pavone. (2021) Single and in combination antiepileptic drug therapy in children with epilepsy: how to use it. AIMS Medical Science 8:2, pages 138-146.
Crossref
Crossref
Lingyan Yu, Jianhua Feng, Zhenwei Yu & Haibin Dai. (2020) Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018. Epilepsy Research 167, pages 106448.
Crossref
Crossref
Alberto Verrotti, Giulia Iapadre, Ludovica Di Francesco, Luca Zagaroli & Giovanni Farello. (2020) Diet in the Treatment of Epilepsy: What We Know So Far. Nutrients 12:9, pages 2645.
Crossref
Crossref
Jonathan J. Halford & Jonathan C. Edwards. (2020) Seizure freedom as an outcome in epilepsy treatment clinical trials. Acta Neurologica Scandinavica 142:2, pages 91-107.
Crossref
Crossref
Monika Mochol, Erik Taubøll, Pål Aukrust, Thor Ueland, Ole A. Andreassen & Sigrid Svalheim. (2020) Interleukin 18 (IL-18) and its binding protein (IL-18BP) are increased in patients with epilepsy suggesting low-grade systemic inflammation. Seizure 80, pages 221-225.
Crossref
Crossref
Jarogniew J. Luszczki, Anna Panasiuk, Mirosław Zagaja, Sławomir Karwan, Hubert Bojar, Zbigniew Plewa & Magdalena Florek-Łuszczki. (2020) Polygonogram and isobolographic analysis of interactions between various novel antiepileptic drugs in the 6-Hz corneal stimulation-induced seizure model in mice. PLOS ONE 15:6, pages e0234070.
Crossref
Crossref